Our mission is to address the unmet medical needs of millions affected by complex genetic conditions, through the discovery of novel biomarkers and drug targets, ending their diagnostic and therapeutic odyssey.
Our mission is to address the unmet medical needs of millions affected by complex genetic conditions, through the discovery of novel biomarkers and drug targets, ending their diagnostic and therapeutic odyssey.
The power of AI merged with genomic data analysis unlocks the blueprint of life enabling us to diagnose earlier and tailoring drugs for effective treatment.
Every individual, regardless of the rarity of their condition, should have access to timely diagnosis and effective treatments, ensuring a life of dignity, potential, and hope.
We work for 350 million rare disease patients, 70% among these are children suffering from 7000+ diseases. Out of these only 5% have FDA approved treatment.
RgenX – DM – A comprehensive genomic analysis solution that accelerates clinical diagnostics for labs.
RgenX – LENS – Provides disease insights and discover novel targets for pharmaceutical companies.
A dynamic database for labs to reclassify and interpret Variants of Uncertain Significance (VUS). It collects, curates, presents, and updates itself, everyday!
An AI powered rare disease diagnosis platform that assists healthcare providers make informed decisions.
